Kings Practice Perth

Your pelvic health matters: insights from NHS clinicians 🌟 Your Pelvic Floor Matters 🌟In this insightful video, we speak to a range of healthcare professionals who share valuable tips on understanding the pelvic ...

📢 𝗡𝗘𝗫𝗣𝗟𝗔𝗡𝗢𝗡 𝗖𝗢𝗡𝗧𝗥𝗔𝗖𝗘𝗣𝗧𝗜𝗩𝗘 𝗜𝗠𝗣𝗟𝗔𝗡𝗧 𝗨𝗣𝗗𝗔𝗧𝗘

We would like to let patients know that the 𝗡𝗲𝘅𝗽𝗹𝗮𝗻𝗼𝗻 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝘃𝗲 𝗶𝗺𝗽𝗹𝗮𝗻𝘁 is now licensed for 𝘂𝗽 𝘁𝗼 𝟱 𝘆𝗲𝗮𝗿𝘀 𝗼𝗳 𝘂𝘀𝗲, instead of the previous 3-year licence.

𝗪𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻𝘀 𝗳𝗼𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀

If you currently have a Nexplanon implant in place, it will continue to provide effective contraception for up to 5 years from the date it was inserted.

This means that many patients who were expecting to have their implant replaced after 3 years no longer need an appointment at this time.

𝗪𝗵𝗲𝗻 𝘁𝗼 𝗰𝗼𝗻𝘁𝗮𝗰𝘁 𝘂𝘀

Please contact the practice if:

• your implant is approaching 5 years since insertion
• you are experiencing side effects or problems with your implant
• you would like the implant removed sooner
• you have any questions or concerns

𝗙𝘂𝗿𝘁𝗵𝗲𝗿 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻

This licensing update follows national guidance from the Faculty of Sexual and Reproductive Healthcare and the updated UK product licence for Nexplanon.

High blood pressure is a silent but serious threat — and knowing your numbers can save your life.
Check your blood pressure regularly and track your readings over time. Aim to keep your blood pressure below 140/90 mmHg — and remember: the lower, the better for your heart, brain, and kidneys.

Taking action today protects your health tomorrow.

Know your numbers. Take control. Stay healthy.

🆕 Introducing our new resource to help people eat and live well while taking medications for obesity.

With 95% of people who take medications for obesity not going through the NHS, few are getting adequate support with understanding how they affect health, how to manage their side effects and what behavioural changes are required to maximise long-term weight loss, once they stop taking them.

This free, first-of-its-kind guide for healthcare professionals and the public provides practical, trustworthy advice to help people optimise outcomes, maintain health and better understand how these medications work.

A huge achievement by the BDA Obesity Specialist Group and everyone involved in developing it.

🔗 Access the guide via the link in the comments ⬇

Novo Nordisk provided a grant and Eli Lilly and Company Limited provided sponsorship to the BDA to support costs of the development and production of this obesity management resource material. Novo Nordisk and Eli Lilly and Company have had no input into or influence over the creation, development or content contained in this material.